Skip to main navigation Skip to search Skip to main content

Decitabine-cedazuridine in patients with MDS and TP53 mutations

  • Samuel Urrutia
  • , Koji Sasaki
  • , Alex Bataller
  • , Hagop Kantarjian
  • , Guillermo Montalban-Bravo
  • , James McCloskey
  • , Elizabeth A. Griffiths
  • , Karen Yee
  • , Amer Zeidan
  • , Michael Savona
  • , Aram Oganesian
  • , Yuri Sano
  • , Harold N. Keer
  • , Guillermo Garcia-Manero
  • Washington University St. Louis
  • University of Texas MD Anderson Cancer Center
  • Hackensack University Medical Center
  • University Health Network
  • Yale University
  • Vanderbilt University
  • Taiho Oncology, Inc.

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)881-886
Number of pages6
JournalBlood Advances
Volume10
Issue number3
DOIs
StatePublished - Feb 10 2026

Fingerprint

Dive into the research topics of 'Decitabine-cedazuridine in patients with MDS and TP53 mutations'. Together they form a unique fingerprint.

Cite this